The influence of parent–child gender on intentions to refuse HPV vaccination due to safety concerns/side effects, National Immunization Survey – Teen, 2010–2019

References

• Chesson HW, Dunne EF, Lawson HW, Markowitz LE, Saraiya M, Unger ER Quadrivalent human papillomavirus vaccine; recommendations of the Advisory Committee on Immunization Practices (ACIP). 2007.
   Google Scholar
• Jemal A, Simard EP, Dorell C, Noone A-M, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)–associated cancers and HPV vaccination coverage levels. Jnci. 2013;105:1–7. doi:10.1093/jnci/djs491.
   PubMedGoogle Scholar
• Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus–associated cancers—United States, 1999–2015. Morbidity Mortality Weekly Report. 2018;67:918. doi:10.15585/mmwr.mm6733a2.
   PubMed Web of Science ®Google Scholar
• Lechner M, Jones OS, Breeze CE, Gilson R. Gender-Neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awareness. Lancet Infect Dis. 2019;19:131–132. doi:10.1016/S1473-3099(18)30802-8.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JJ, Unger ER. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity Mortality Weekly Report. 2014;63:1–30.
   PubMed Web of Science ®Google Scholar
• Daley EM, Vamos CA, Thompson EL, Zimet GD, Rosberger Z, Merrell L, Kline NS. The feminization of HPV: how science, politics, economics and gender norms shaped US HPV vaccine implementation. Papillomavirus Res. 2017;3:142–148. doi:10.1016/j.pvr.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Thompson EL, Rosen BL, Vamos CA, Kadono M, Daley EM. Human papillomavirus vaccination: what are the reasons for nonvaccination among US adolescents? J Adolescent Health. 2017;61:288–293. doi:10.1016/j.jadohealth.2017.05.015.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Moss JL, McRee A-L, Brewer NT. Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine. 2012;30:5928–5934. doi:10.1016/j.vaccine.2012.07.045.
   PubMed Web of Science ®Google Scholar
• Little DT, Ward HRG. Adolescent premature ovarian insufficiency following human papillomavirus vaccination: a case series seen in general practice. J Invest Med High Impact Case Rep. 2014;2:2324709614556129. doi:10.1177/2324709614556129.
   Google Scholar
• Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants. Am J Reprod Immunol. 2013;70:309–316. doi:10.1111/aji.12151.
   PubMed Web of Science ®Google Scholar
• Christianson MS, Wodi P, Talaat K, Halsey N. Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence. Am J Obstet Gynecol. 2020;222:239–244. doi:10.1016/j.ajog.2019.08.045.
   PubMed Web of Science ®Google Scholar
• Reiter PL, McRee A-L, Pepper JK, Gilkey MB, Galbraith KV, Brewer NT. Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health. 2013;103:1419–1427. doi:10.2105/AJPH.2012.301189.
   PubMed Web of Science ®Google Scholar
• Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168:76–82. doi:10.1001/jamapediatrics.2013.2752.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, McRee A-L. Provider communication about HPV vaccination: a systematic review. Human Vaccines & Immunotherapeutics. 2016;12:1454–1468. doi:10.1080/21645515.2015.1129090.
   PubMed Web of Science ®Google Scholar
• Sonawane K, Zhu Y, Lin Y-Y, Damgacioglu H, Lin Y, Montealegre JR, Deshmukh AA. HPV vaccine recommendations and parental intent. Pediatrics. 2021;147. doi:10.1542/peds.2020-026286.
   Web of Science ®Google Scholar
• Chido-Amajuoyi OG, Talluri R, Shete SS, Shete S. Safety Concerns or Adverse Effects as the Main Reason for Human Papillomavirus Vaccine Refusal: National Immunization Survey–Teen, 2008 to 2019. JAMA Pediatr. 2021;175:1074–1076. doi:10.1001/jamapediatrics.2021.1585.
   PubMed Web of Science ®Google Scholar
• Hirth JM, Fuchs EL, Chang M, Fernandez ME, Berenson AB. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008–2016). Vaccine. 2019;37:595–601. doi:10.1016/j.vaccine.2018.12.017.
   PubMed Web of Science ®Google Scholar
• Vadaparampil ST, Malo TL, Kahn JA, Salmon DA, Lee J-H, Quinn GP, Roetzheim RG, Bruder KL, Proveaux TM, Zhao X. Physicians’ human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med. 2014;46:80–84. doi:10.1016/j.amepre.2013.07.009.
   PubMed Web of Science ®Google Scholar
• Gilkey MB, Calo WA, Marciniak MW, Brewer NT. Parents who refuse or delay HPV vaccine: differences in vaccination behavior, beliefs, and clinical communication preferences. Human Vaccines & Immunotherapeutics. 2017;13:680–686. doi:10.1080/21645515.2016.1247134.
   PubMed Web of Science ®Google Scholar
• Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Human Vaccines & Immunotherapeutics. 2017;13:2713–2722. doi:10.1080/21645515.2017.1363133.
   PubMed Web of Science ®Google Scholar
• Chido-Amajuoyi OG, Domgue JF, Obi-Jeff C, Schmeler K, Shete S. A call for the introduction of gender-neutral HPV vaccination to national immunisation programmes in Africa. The Lancet Global Health. 2019;7:e20–e1. doi:10.1016/S2214-109X(18)30405-4.
   PubMed Web of Science ®Google Scholar
• Qendri V, Bogaards JA, Baussano I, Lazzarato F, Vänskä S, Berkhof J. The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment. The Lancet Public Health. 2020;5:e592–e603. doi:10.1016/S2468-2667(20)30209-7.
   PubMed Web of Science ®Google Scholar
• Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE. The cost-effectiveness of male HPV vaccination in the United States. Vaccine. 2011;29:8443–8450. doi:10.1016/j.vaccine.2011.07.096.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC) National Opinion Research Center at the University of Chicago. National Immunization Survey-Teen: a User’s Guide for the 2016 Public-Use data file. Chicago, IL: National Opinion Research Center; 2016.
   Google Scholar
• Jain N, Singleton JA, Montgomery M, Skalland B. Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006. Public Health Rep. 2009;124:642–651. doi:10.1177/003335490912400506.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:874. doi:10.15585/mmwr.mm6633a2.
   PubMed Web of Science ®Google Scholar
• Moss JL. Evolving trends in human papillomavirus vaccination by sex and time: implications for clinicians and interventionists. J Adolescent Health. 2017;61:269–270. doi:10.1016/j.jadohealth.2017.06.004.
   PubMed Web of Science ®Google Scholar
• Chido-Amajuoyi OG, Talluri R, Wonodi C, Shete S. Trends in HPV vaccination initiation and completion within ages 9–12 Years: 2008–2018. Pediatrics. 2021;147. doi:10.1542/peds.2020-012765.
   PubMed Web of Science ®Google Scholar
• Bednarczyk RA. Addressing HPV vaccine myths: practical information for healthcare providers. Human Vaccines & Immunotherapeutics. 2019;15:1628–1638. doi:10.1080/21645515.2019.1565267.
   PubMed Web of Science ®Google Scholar
• Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW. Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation. Prev Med. 2013;57:414–418. doi:10.1016/j.ypmed.2013.05.013.
   PubMed Web of Science ®Google Scholar
• Chido-Amajuoyi OG, Jackson I, Yu R, Shete S. Declining awareness of HPV and HPV vaccine within the general US population. Human Vaccines & Immunotherapeutics. 2021;17:420–427. doi:10.1080/21645515.2020.1783952.
   PubMed Web of Science ®Google Scholar